Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.
Ophélie Rouxel, Jennifer Da Silva, Lucie Beaudoin...
https://pubmed.ncbi.nlm.nih.gov/28991267/Actively Recruiting
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2026-10-27
180
Participants Needed
2
Research Sites
N/A
Total Duration
This research investigates how Mucosal-Associated Invariant T MAIT cells interact with the gut microbiota and mucosa in children with or at risk of type 1 diabetes T1D. It evaluates changes in MAIT cell frequency, function, and phenotype, linking them to gut health, the presence of Coxsackie virus B, and T1D development. The study involves pediatric patients recently diagnosed with T1D, those at high genetic risk, and control groups. Participants are grouped into recent-onset T1D patients, at-risk siblings with specific genetic markers, control patients without T1D risk, and controls undergoing upper gastrointestinal UGI endoscopy for other medical reasons. The study collects blood, stool, and urine samples to analyze MAIT cells, gut microbiota, viral infection, and gut integrity. Selected patients undergo UGI endoscopy for duodenal biopsies to study mucosal changes. Participants provide samples at enrollment, including blood for MAIT cell and antibody analyses, stool for microbiota and viral testing, and urine for gut permeability tests. Some undergo endoscopy for tissue biopsies. Researchers assess immune markers, gut mucosa health, and viral presence, aiming to understand MAIT cells as biomarkers for T1D progression. The study lasts until August 2027, with data collected mainly at enrollment and in selected subgroups.
CONDITIONS
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
J
jacques beltrand, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Institut National de la Santé Et de la Recherche Médicale, France
Lead Sponsor
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At enrollment and as needed
Participants provide blood, stool, and urine samples for MAIT cell, gut microbiota, viral infection, and gut integrity analyses. Selected participants undergo upper gastrointestinal endoscopy for duodenal biopsies to study gut mucosa.
1 visit for sample collection; additional visit for endoscopy if applicable
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Ophélie Rouxel, Jennifer Da Silva, Lucie Beaudoin...
https://pubmed.ncbi.nlm.nih.gov/28991267/Matthieu Rouland, Lucie Beaudoin, Ophélie Rouxel...
https://pubmed.ncbi.nlm.nih.gov/33593807/Institut National de la Santé Et de la Recherche Médicale, France
Lead Sponsor
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Collaborating Sponsor